Medtech Acquisition Book Value Per Share vs. Current Valuation
| MTACUDelisted Stock | USD 9.86 0.00 0.00% |
For Medtech Acquisition profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medtech Acquisition to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medtech Acquisition Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medtech Acquisition's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medtech Acquisition Corp over time as well as its relative position and ranking within its peers.
Medtech |
Medtech Acquisition Corp Current Valuation vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medtech Acquisition's current stock value. Our valuation model uses many indicators to compare Medtech Acquisition value to that of its competitors to determine the firm's financial worth. Medtech Acquisition Corp is considered to be number one stock in book value per share category among its peers. It also is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Medtech Acquisition by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Medtech Current Valuation vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Medtech Acquisition |
| = | (2.42) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Medtech Acquisition |
| = | 81.09 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Medtech Current Valuation vs Competition
Medtech Acquisition Corp is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Financials industry is now estimated at about 162.19 Million. Medtech Acquisition totals roughly 81.09 Million in current valuation claiming about 50% of equities under Financials industry.
Medtech Acquisition Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Medtech Acquisition, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medtech Acquisition will eventually generate negative long term returns. The profitability progress is the general direction of Medtech Acquisition's change in net profit over the period of time. It can combine multiple indicators of Medtech Acquisition, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MedTech Acquisition Corporation does not have significant operations. The company was incorporated in 2020 and is based in Greenwich, Connecticut. Medtech Acquisition is traded on NASDAQ Exchange in the United States.
Medtech Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medtech Acquisition. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medtech Acquisition position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medtech Acquisition's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Medtech Acquisition without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Use Investing Themes to Complement your Medtech Acquisition position
In addition to having Medtech Acquisition in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Medical Equipment Thematic Idea Now
Medical Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Medical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Medical Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |